Pro-Dex (NASDAQ:PDEX) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Pro-Dex (NASDAQ:PDEX) in a report released on Wednesday. The brokerage issued a buy rating on the medical instruments supplier’s stock.

Pro-Dex Stock Performance

Pro-Dex stock opened at $16.00 on Wednesday. The firm has a market capitalization of $56.80 million, a P/E ratio of 12.60 and a beta of 0.92. The company’s 50-day moving average is $17.44 and its 200 day moving average is $17.34. Pro-Dex has a 1-year low of $14.47 and a 1-year high of $21.00. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.07 and a quick ratio of 1.58.

Institutional Trading of Pro-Dex

Several institutional investors and hedge funds have recently modified their holdings of PDEX. Renaissance Technologies LLC bought a new stake in shares of Pro-Dex during the second quarter valued at approximately $168,000. JPMorgan Chase & Co. raised its stake in shares of Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier’s stock valued at $345,000 after acquiring an additional 7,762 shares in the last quarter. Punch & Associates Investment Management Inc. raised its stake in shares of Pro-Dex by 13.5% during the first quarter. Punch & Associates Investment Management Inc. now owns 63,075 shares of the medical instruments supplier’s stock valued at $1,035,000 after acquiring an additional 7,480 shares in the last quarter. UBS Group AG raised its stake in shares of Pro-Dex by 421.5% during the first quarter. UBS Group AG now owns 5,867 shares of the medical instruments supplier’s stock valued at $96,000 after acquiring an additional 4,742 shares in the last quarter. Finally, LSV Asset Management raised its stake in shares of Pro-Dex by 13.9% during the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier’s stock valued at $588,000 after acquiring an additional 4,346 shares in the last quarter. Institutional investors own 14.78% of the company’s stock.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.